Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06887205 · ClinicalTrials.gov registry record · NA
Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study
A NA study, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 20
- Enrollment target
NCT06887205: Recruiting NA study, sponsored by M.D. Anderson Cancer Center.
NCT06887205 is a NA study that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06887205, a NA study, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 20 participants
- Enrollment target
Study Summary
To learn if LBP can help to prevent lymphedema when it is performed at the time of surgery rather than after a patient has already developed the disease.
Interventions
- PROCEDURE Lymphovenous bypass (LVB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2026-06-10 |
| Est. Completion | 2028-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06887205
The ClinicalTrials.gov registry entry for NCT06887205 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 20 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Lymphovenous bypass (LVB) is the first listed.
NCT06887205 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT06887205 about?
NCT06887205 is a clinical study titled "Immediate Lymphatic Reconstruction After Lymphadenectomy in Melanoma Patients: a Parallel Cohort Pilot Study". To learn if LBP can help to prevent lymphedema when it is performed at the time of surgery rather than after a patient has already developed the disease.
What is the current status of trial NCT06887205?
This trial is currently recruiting. It is a NA study. The enrollment target is 20 participants. The study started on 2026-06-10. Estimated completion is 2028-09-01.
What interventions are being tested in trial NCT06887205?
The interventions under investigation include: Lymphovenous bypass (LVB) (PROCEDURE).
Who is sponsoring clinical trial NCT06887205?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.